Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Neoadjuvant IAG and CGI Chemotherapy for Locally Advanced Urothelial Cancer
NCT00080795Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2001
- Primary completion
- May 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, doxorubicin, gemcitabine, cisplatin in urothelial carcinoma (UC), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2001; status: completed.
02
Drugs
ifosfamidedoxorubicingemcitabinecisplatin
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00080795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080795.